| Peginterferon Alfa-2b studied in …STUDIED_INderived50 of 50show fewer |
|---|
| → studied in | NCT00539591Phase 2 · active not recruiting Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07553767early Phase 1 · not yet recruiting Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection · 50 trials list this drug (3 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02737046Phase 2 · completed Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma · 50 trials list this drug (3 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05870475Phase 2 · recruiting Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV · 50 trials list this drug (3 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00574730NA · completed CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma · 50 trials list this drug (3 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00846430Phase 2 · completed Medical Treatment of "High-Risk" Neurofibromas · 50 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049530Phase 2 · completed PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00134030Phase 3 · completed Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma · 50 trials list this drug (3 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02634294Phase 2/Phase 3 · completed Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT · 50 trials list this drug (3 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02218164Phase 2 · completed Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma · 50 trials list this drug (3 active) | — | — | Squamous Cell Carcinoma,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01387763Phase 3 · completed A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms · 50 trials list this drug (3 active) | — | — | Essential Thrombocythemia,Polycythemia Vera,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04246359Phase 2 · unknown Rituximab and Pegylated Interferon α-2b in Patients With Indolent B-cell Lymphoma · 50 trials list this drug (3 active) | — | — | B-Cell Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02982720Phase 2 · terminated Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron · 50 trials list this drug (3 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02343224Phase 2 · completed Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas · 50 trials list this drug (3 active) | — | — | Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02112032Phase 1 · completed Treatment of Advanced Melanoma With MK-3475 and Peginterferon · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00525031Phase 2 · completed Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02379195Phase 1/Phase 2 · completed Peginterferon and TIL Therapy for Metastatic Melanoma · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03547154Phase 2/Phase 3 · terminated Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026) · 50 trials list this drug (3 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03552549Phase 2/Phase 3 · terminated SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002) · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03554005Phase 1 · completed Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009) · 50 trials list this drug (3 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01502696Phase 3 · unknown Adjuvant PEG Intron in Ulcerated Melanoma · 50 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00724061NA · terminated Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL · 50 trials list this drug (3 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00791271Phase 1 · terminated Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00037882Phase 2 · terminated PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron · 50 trials list this drug (3 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01866553Phase 2 · terminated Nilotinib Plus Pegylated Interferon-α2b in CML · 50 trials list this drug (3 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02155322Phase 2 · completed A Phase II Study of Pegylated Interferon Alfa-2b for the Adjuvant Treatment of Melanoma Subjects in Russia (MK-4031-400) · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00415857Phase 2 · terminated Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R) · 50 trials list this drug (3 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01636960Phase 1 · terminated A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370) · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00090870Phase 2 · terminated PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer · 50 trials list this drug (3 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00854581Phase 4 · terminated Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma · 50 trials list this drug (3 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014261Phase 1 · completed Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors · 50 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00396019Phase 2 · completed Study of PEG-Intron for Plexiform Neurofibromas · 50 trials list this drug (3 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00457418Phase 1 · completed High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2) · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01496807Phase 1 · completed Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00759109Phase 3 · completed Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085) · 50 trials list this drug (3 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00467077Phase 2 · terminated Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer · 50 trials list this drug (3 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00861406Phase 1 · completed Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00303290Phase 1 · completed PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML · 50 trials list this drug (3 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589550Phase 1 · terminated PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer · 50 trials list this drug (3 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00701298Phase 1 · terminated Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors · 50 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045279Phase 2 · completed PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer · 50 trials list this drug (3 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238329Phase 2 · completed PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma · 50 trials list this drug (3 active) | — | — | Melanoma,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055809Phase 2 · completed Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors · 50 trials list this drug (3 active) | — | — | Digestive System Neuroendocrine Tumor G1,Regional Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00276523Phase 2 · completed PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery · 50 trials list this drug (3 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085384Phase 1/Phase 2 · terminated PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer · 50 trials list this drug (3 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047879Phase 2 · completed Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas · 50 trials list this drug (3 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01325896Phase 2 · unknown Maintenance Treatment of Multiple Myeloma (MM) After Autologous Peripheral Blood Transplant (PBSCT) Using Polyethylene Glycol alpha2B Interpheron (PEG-INTRON) · 50 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00746746Phase 2 · unknown A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00623402Phase 2 · completed Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00221702Phase 3 · completed PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial) · 50 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |